Search Results - "Duffy, Carol I."

Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists by Ambrosy, Andrew P., Braunwald, Eugene, Morrow, David A., DeVore, Adam D., McCague, Kevin, Meng, Xiangyi, Duffy, Carol I., Rocha, Ricardo, Velazquez, Eric J.

“…The PIONEER-HF (comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode) trial…”
Get full text

Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial by Berg, David D., Samsky, Marc D., Velazquez, Eric J., Duffy, Carol I., Gurmu, Yared, Braunwald, Eugene, Morrow, David A., DeVore, Adam D.

“…In patients stabilized during hospitalization for acute decompensated heart failure (HF), initiation of sacubitril/valsartan compared with enalapril decreased…”
Get full text

Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial by DeVore, Adam D, Mi, Xiaojuan, Thomas, Laine, Sharma, Puza P, Albert, Nancy M, Butler, Javed, Hernandez, Adrian F, Patterson, J Herbert, Spertus, John A, Williams, Fredonia B, Duffy, Carol I, McCague, Kevin, Fonarow, Gregg C

“…The US Food and Drug Administration approved sacubitril/valsartan for patients with chronic heart failure (HF) with reduced ejection fraction in 2015 on the…”
Get full text

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure by Velazquez, Eric J, Morrow, David A, DeVore, Adam D, Duffy, Carol I, Ambrosy, Andrew P, McCague, Kevin, Rocha, Ricardo, Braunwald, Eugene

“…Patients with acute decompensated heart failure were randomly assigned to receive sacubitril–valsartan or enalapril. At 8 weeks, the sacubitril–valsartan group…”
Get full text

Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry by Greene, Stephen J, Butler, Javed, Albert, Nancy M, DeVore, Adam D, Sharma, Puza P, Duffy, Carol I, Hill, C Larry, McCague, Kevin, Mi, Xiaojuan, Patterson, J Herbert, Spertus, John A, Thomas, Laine, Williams, Fredonia B, Hernandez, Adrian F, Fonarow, Gregg C

“…Guidelines strongly recommend patients with heart failure with reduced ejection fraction (HFrEF) be treated with multiple medications proven to improve…”
Get full text

Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry by Khariton, Yevgeniy, Fonarow, Gregg C., Hellkamp, Ann, Thomas, Laine, Nassif, Michael E., Butler, Javed, Duffy, Carol I., Albert, Nancy M., Spertus, John A.

“…Aims The aim of our study was to investigate heterogeneity of health status treatment response of sacubitril/valsartan in patients with heart failure with…”
Get full text

Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction by Greene, Stephen J., Fonarow, Gregg C., DeVore, Adam D., Sharma, Puza P., Vaduganathan, Muthiah, Albert, Nancy M., Duffy, Carol I., Hill, C. Larry, McCague, Kevin, Patterson, J. Herbert, Spertus, John A., Thomas, Laine, Williams, Fredonia B., Hernandez, Adrian F., Butler, Javed

“…Guidelines recommend that patients with heart failure with reduced ejection fraction (HFrEF) have medical therapy titrated to target doses derived from…”
Get full text

Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial by Morrow, David A, Velazquez, Eric J, DeVore, Adam D, Desai, Akshay S, Duffy, Carol I, Ambrosy, Andrew P, Gurmu, Yared, McCague, Kevin, Rocha, Ricardo, Braunwald, Eugene

Get full text

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial by Morrow, David A, Velazquez, Eric J, DeVore, Adam D, Prescott, Margaret F, Duffy, Carol I, Gurmu, Yared, McCague, Kevin, Rocha, Ricardo, Braunwald, Eugene

“…Abstract Aims Circulating high-sensitivity cardiac troponin (hsTn) and soluble ST2 (sST2) reflect myocardial stress in patients with heart failure (HF)…”
Get full text

Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial by Velazquez, Eric J., Morrow, David A., DeVore, Adam D., Ambrosy, Andrew P., Duffy, Carol I., McCague, Kevin, Hernandez, Adrian F., Rocha, Ricardo A., Braunwald, Eugene

“…The objective is to assess the safety, tolerability, and efficacy of sacubitril/valsartan compared with enalapril in patients with heart failure (HF) with a…”
Get full text

Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction by Greene, Stephen J, Butler, Javed, Spertus, John A, Hellkamp, Anne S, Vaduganathan, Muthiah, DeVore, Adam D, Albert, Nancy M, Duffy, Carol I, Patterson, J Herbert, Thomas, Laine, Williams, Fredonia B, Hernandez, Adrian F, Fonarow, Gregg C

“…It is unclear how New York Heart Association (NYHA) functional class compares with patient-reported outcomes among patients with heart failure (HF) in…”
Get more information

Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients by Srivastava, Pratyaksh K., DeVore, Adam D., Hellkamp, Anne S., Thomas, Laine, Albert, Nancy M., Butler, Javed, Patterson, J. Herbert, Spertus, John A., Williams, Fredonia B., Duffy, Carol I., Hernandez, Adrian F., Fonarow, Gregg C.

“…The authors sought to evaluate the association of heart failure hospitalization (HFH) with guideline-directed medical therapy (GDMT) prescribing patterns among…”
Get full text

Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial by DeVore, Adam D, Braunwald, Eugene, Morrow, David A, Duffy, Carol I, Ambrosy, Andrew P, Chakraborty, Hrishikesh, McCague, Kevin, Rocha, Ricardo, Velazquez, Eric J

“…In PIONEER-HF, among stabilized patients with acute decompensated heart failure (ADHF), the in-hospital initiation of sacubitril/valsartan was well tolerated…”
Get more information

Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry by Peri-Okonny, Poghni A, Mi, Xiaojuan, Khariton, Yevgeniy, Patel, Krishna K, Thomas, Laine, Fonarow, Gregg C, Sharma, Puza P, Duffy, Carol I, Albert, Nancy M, Butler, Javed, Hernandez, Adrian F, McCague, Kevin, Williams, Fredonia B, DeVore, Adam D, Patterson, J Herbert, Spertus, John A

“…This study sought to determine the rate of use of target doses of foundational guideline-directed medical therapy (GDMT) in a contemporary cohort of patients…”
Get full text

Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry by Vaduganathan, Muthiah, Fonarow, Gregg C, Greene, Stephen J, DeVore, Adam D, Kavati, Abhishek, Sikirica, Slaven, Albert, Nancy M, Duffy, Carol I, Hill, C Larry, Patterson, J Herbert, Spertus, John A, Thomas, Laine E, Williams, Fredonia B, Hernandez, Adrian F, Butler, Javed

“…The purpose of this study was to characterize the clinical profile, treatment patterns, and clinical outcomes of patients with comorbid diabetes mellitus (DM)…”
Get full text

Change the Management of Patients with Heart Failure: Rationale and Design of the CHAMP-HF Registry by DeVore, Adam D, Thomas, Laine, Albert, Nancy M, Butler, Javed, Hernandez, Adrian F, Patterson, J. Herbert, Spertus, John A, Williams, Fredonia B, Turner, Stuart J, Chan, Wing W, Duffy, Carol I, McCague, Kevin, Mi, Xiaojuan, Fonarow, Gregg C

“…Abstract Heart failure (HF) with reduced ejection fraction (HFrEF) is a common and costly condition that diminishes patients' health status and confers a poor…”
Get full text

Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF by DeVore, Adam D., Hellkamp, Anne S., Thomas, Laine, Albert, Nancy M., Butler, Javed, Patterson, J. Herbert, Spertus, John A., Williams, Fredonia B., Duffy, Carol I., Hernandez, Adrian F., Fonarow, Gregg C.

“…Background: Among patients with heart failure (HF) with reduced ejection fraction (EF), improvements in left ventricular EF (LVEF) are associated with better…”
Get full text

Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF) by Giblin, Erika M., Adams, Kirkwood F., Hill, Larry, Fonarow, Gregg C., Williams, Fredonia B., Sharma, Puza P., Albert, Nancy M., Butler, Javed, DeVore, Adam D., Duffy, Carol I., Hernandez, Adrian F., McCague, Kevin, Spertus, John A., Thomas, Laine, Patterson, J. Herbert

“…Underuse of hydralazine/nitrate (HYD/NIT) in black patients with heart failure and reduced ejection fraction (HFrEF) has been previously described, but whether…”
Get full text

Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States by DeVore, Adam D, Hill, C Larry, Thomas, Laine, Sharma, Puza P, Albert, Nancy M, Butler, Javed, Patterson, J Herbert, Spertus, John A, Williams, Fredonia B, Duffy, Carol I, McCague, Kevin, Hernandez, Adrian F, Fonarow, Gregg C

“…Background Current guidelines recommend sacubitril/valsartan for patients with heart failure with reduced ejection fraction, but the rate of adoption in the…”
Get full text

Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction by Vaduganathan, Muthiah, Fonarow, Gregg C., Greene, Stephen J., Devore, Adam D., Albert, Nancy M., Duffy, Carol I., Hill, C. Larry, Patterson, J. Herbert, Spertus, John A., Thomas, Laine E., Williams, Fredonia B., Hernandez, Adrian F., Butler, Javed

“…Clinical practice guidelines support sustained use of renin-angiotensin-aldosterone-system (RAAS) inhibitors over time in heart failure with reduced ejection…”
Get full text